MSL
CLVS

Mackay Shields LLC’s Clovis Oncology, Inc. CLVS Stock Holding History

Mackay Shields LLC’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-61,078
Closed -$908K – 1526
2019
Q2 		$908K Buy
61,078
+43,978
+257% +$795K 0.01% 1149
2019
Q1 		$424K Sell
17,100
-8,181
-32% -$205K ﹤0.01% 1216
2018
Q4 		$454K Buy
25,281
+7,148
+39% +$146K ﹤0.01% 1168
2018
Q3 		$533K Buy
18,133
+2,400
+15% +$92.9K ﹤0.01% 994
2018
Q2 		$716K Hold
15,733
– – 0.01% 1027
2018
Q1 		$831K Buy
+15,733
New +$918K 0.01% 1017

Other funds holding CLVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Mackay Shields LLC's CLVS Position: Q3 2019 in Review

Mackay Shields LLC sold out of Clovis Oncology, Inc. (CLVS) in Q3 2019, closing a stake of 61,078 shares — an estimated $908K sold.

Mackay Shields LLC first reported a position in CLVS in Q1 2018 and held it in 6 quarters. The position peaked at $908K in Q2 2019. 153 funds tracked by Wall St. Rank hold CLVS as of Q3 2019.

  • Mackay Shields LLC reported no remaining Clovis Oncology, Inc. position as of Q3 2019 after selling out during the quarter.
  • Mackay Shields LLC sold 61,078 Clovis Oncology, Inc. shares in Q3 2019, an estimated $908K.
  • Mackay Shields LLC first reported a position in Clovis Oncology, Inc. in Q1 2018 and held it in 6 quarters.
  • Mackay Shields LLC's Clovis Oncology, Inc. position peaked at $908K in Q2 2019.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2019.

Based on Mackay Shields LLC's 13F filing for Q3 2019, filed 1 Nov 2019.